Konami Holdings Corp (KNM)
London Exchange · UK · prices in JPY · close of 16 Oct 2026
Key indicators
| Last close | JPY 24,010.00 |
|---|---|
| 52-week range | 16,372.00 – 25,420.91 |
| Return, 1 month / 3 months | +10.0% / +23.3% |
| Return, 1 year / 3 years | +33.2% / – |
| Trend | Uptrend |
| RSI (14) | 70 |
| Volatility (1 year) | 51.3% |
| Worst drawdown (1 year) | -32.4% |
| Average daily value traded | 186.26M JPY |
| Dividend yield | 1.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Konami Holdings is a Japanese entertainment company based in Tokyo. It develops and publishes video games for consoles and mobile devices, including long-running series in action, sports and role-playing genres. The company also runs fitness and health clubs in Japan and produces arcade and amusement machines for game centres. Its customers include home gamers, arcade operators and gym members, and its activities span digital entertainment, amusement equipment and sports and health services.
Konami Holdings Corp trades under the code KNM on the London Exchange in UK, with its price quoted in Japanese yen (JPY). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Konami Holdings Corp (KNM) trades on the London Exchange in UK. It last closed at JPY 24,010.00 on 16 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 714 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 33.2% and over the last three months it rose 23.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 78 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | – | ||
| From 52-week high | -5.6% | ||
| Momentum | 84 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 23.3% | ||
| 6-month return | 16.9% | ||
| 12-month return, skipping the last month | – | ||
| Stability (higher is calmer) | 35 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 51.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.4% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 186.26M JPY | ||
| Zero-volume days | 0.0% | ||
| Income | 44 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +9.3% |
|---|---|
| 1 month | +10.0% |
| 3 months | +23.3% |
| 6 months | +16.9% |
| 1 year | +33.2% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 20,775.95 / 20,817.42 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 506.18 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Sep 2026 | JPY 112.0000 |
| 30 Mar 2026 | JPY 138.5000 |
| 29 Sep 2025 | JPY 83.0000 |
| 28 Mar 2025 | JPY 99.5000 |
| 27 Sep 2024 | JPY 66.0000 |
| 28 Mar 2024 | JPY 69.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.